Lineage Cell Therapeutics, Inc. (LCTX)
1.03
+0.08
(+8.70%)
USD |
NYAM |
Oct 08, 14:25
Lineage Cell Therapeutics Price : 1.03 for Oct. 8, 2026
Price Chart
Historical Price Data
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Oct 07, 2026 | 0.9424 | 0.965 | 0.9212 | 0.9476 | 1.477M |
| Oct 06, 2026 | 0.9411 | 0.965 | 0.925 | 0.9379 | 967621.0 |
| Oct 05, 2026 | 0.93 | 0.9604 | 0.9118 | 0.9274 | 1.387M |
| Oct 02, 2026 | 0.921 | 0.96 | 0.8913 | 0.9303 | 1.249M |
| Oct 01, 2026 | 0.9581 | 0.97 | 0.8823 | 0.9042 | 1.652M |
| Sep 30, 2026 | 0.9503 | 0.9882 | 0.9421 | 0.9557 | 1.268M |
| Sep 29, 2026 | 0.98 | 0.99 | 0.9202 | 0.9475 | 2.592M |
| Sep 28, 2026 | 1.02 | 1.04 | 0.96 | 0.971 | 1.574M |
| Sep 25, 2026 | 0.95 | 1.04 | 0.9419 | 1.03 | 2.482M |
| Sep 24, 2026 | 0.9519 | 0.9692 | 0.9101 | 0.9478 | 2.440M |
| Sep 23, 2026 | 1.02 | 1.04 | 0.9551 | 0.9567 | 2.631M |
| Sep 22, 2026 | 1.02 | 1.05 | 1.00 | 1.04 | 847525.0 |
| Sep 21, 2026 | 1.03 | 1.046 | 1.005 | 1.01 | 730633.0 |
| Sep 18, 2026 | 1.02 | 1.055 | 1.00 | 1.03 | 3.209M |
| Sep 17, 2026 | 1.10 | 1.10 | 1.025 | 1.03 | 901699.0 |
| Sep 16, 2026 | 1.06 | 1.12 | 1.03 | 1.07 | 1.639M |
| Sep 15, 2026 | 1.06 | 1.07 | 1.02 | 1.06 | 1.400M |
| Sep 14, 2026 | 1.01 | 1.08 | 1.01 | 1.07 | 1.840M |
| Sep 11, 2026 | 1.02 | 1.03 | 1.00 | 1.01 | 913446.0 |
| Sep 10, 2026 | 1.02 | 1.029 | 1.00 | 1.02 | 1.198M |
| Sep 09, 2026 | 1.11 | 1.12 | 1.03 | 1.03 | 1.364M |
| Sep 08, 2026 | 1.10 | 1.16 | 1.09 | 1.09 | 1.312M |
| Sep 04, 2026 | 1.09 | 1.105 | 1.08 | 1.08 | 535726.0 |
| Sep 03, 2026 | 1.11 | 1.12 | 1.085 | 1.10 | 917013.0 |
| Sep 02, 2026 | 1.08 | 1.135 | 1.08 | 1.11 | 675975.0 |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price Benchmarks
| Agenus, Inc. | 7.55 |
| Amgen, Inc. | 405.51 |
| BioCryst Pharmaceuticals, Inc. | 8.31 |
| Imunon, Inc. | 1.08 |
| Curis, Inc. | 0.6753 |
Price Related Metrics
| PS Ratio | 19.58 |
| PEG Ratio | -6.003 |
| Price to Book Value | 4.276 |
| Earnings Yield | -17.89% |
| Market Cap | 260.49M |
| PEGY Ratio | -6.003 |